The Irish Medicines Verification Organisation (IMVO) has today announced the appointment of Paul Reid as Independent Chair of its Board.
Paul brings extensive leadership experience across the public, private and not-for-profit sectors. Paul previously served as CEO of the Health Service Executive (HSE) from May 2019 to December 2022, where he led Ireland’s health service through the Covid-19 global pandemic and a significant criminal cyber-attack, while acting as a key advisor to Government and communicator to the public.
With deep expertise as a board chairperson, non-executive director and CEO, he is currently Chair of An Coimisiún Pleanála, Ireland’s national and independent planning authority, and Chair of Ashdale Care, which provides specialist residential care services for children and young people.
Commenting on his appointment, Paul Reid said: “I’m delighted to be joining the board of IMVO as Chair. The organisation plays a key role in protecting the public and patients, which is something that I’m highly committed to”.
Leonie Clarke, Chief Executive of IMVO, welcomed the appointment saying: “We are delighted to welcome Paul as Independent Chair of IMVO. His depth of experience, knowledge of healthcare in Ireland and unwavering commitment to public service will be invaluable as we work towards our vision of a secure and sustainable medicines supply chain where patients are confident about the authenticity of prescription medicines they receive in the Irish healthcare system.”
IMVO was established in 2017 to manage the Irish Medicines Verification System (IMVS) and works to ensure a secure and effective medicines verification system that protects patients from falsified medicines entering the legitimate supply chain in Ireland.
Paul succeeds Professor Pat O’Mahony, who served as Independent Chair from June 2017 until his unexpected passing in August 2025.
ENDS
For further Information;
Danny Hanley, Káno Communications
0861759286
Claire Egan, Káno Communications
0868653507
Latest News